Abbott India · NSE: ABBOTINDIA · BSE: 500488
Q4 FY24 results · Jan–Mar 2024
Abbott India reported revenue from operations of ₹1,438.63 crore (up 7.1% from Q4 FY23) and net profit of ₹287.06 crore (up 24.0% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a standalone basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,438.63 | 1,343.08 | +7.1% | 1,437.14 | +0.1% |
| Other income | 81.15 | 49.64 | +63.5% | 55.61 | +45.9% |
| Total income | 1,519.78 | 1,392.72 | +9.1% | 1,492.75 | +1.8% |
| Profit before tax | 389.68 | 308.41 | +26.4% | 422.16 | −7.7% |
| Net profit for the period | 287.06 | 231.42 | +24.0% | 310.98 | −7.7% |
| EPS, basic (₹) | 565.28 | 108.90 | +419.1% | 146.34 | +286.3% |
| Net margin (%) | 20.0 | 17.2 | 21.6 |
Standalone
- Filed with BSE
- 10 May 2024, 11:21 IST
- Board meeting
- 09 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE